Could another acquisition involving Incyte be more likely, though? Here are some potential 2017 acquisition scenarios for Incyte: with Gilead, Agenus There are plenty of reasons why Gilead might want to buy Incyte next year. The big biotech has plenty of cash to spend.
Category: Deal or No Deal
The Most Likely Incyte Acquisition Deal for 2017?
Could another acquisition involving Incyte be more likely, though? Here are some potential 2017 acquisition scenarios for Incyte: with Gilead, Agenus There are plenty of reasons why Gilead might want to buy Incyte next year. The big biotech has plenty of cash to spend.